Fecal Matters: Clinician and Laboratorian Perspective on Impact of Molecular GI Pathogen Testing
May 18, 2017 - Toronto ON CAXtalks Life Science Webinars
ajuurinen@xtalks.com
Phone:416 977 6555 ex 371
Rapid diagnostics for stool pathogens have only recently emerged as viable options for testing for community-acquired diarrhea. Antibody-mediated EIA methods have shown the ability to shorten turnaround times for such stool pathogens as shiga-toxin producing E. coli (STEC), however, these kits lack the multiplexing capabilities necessary to replace culture for routine screening and may still require 12-24 hour turnaround times.
This website uses cookies to ensure you get the best experience on our website. Learn more